Team Category: Leadership Team

Mr. Frohlich is the Chief Executive Officer and a member of the Jade Biosciences Board of Directors. From June 2021 to October 2023, Mr. Frohlich served as Chief Operating Officer and, from January 2019 to June 2021, as Chief Business Officer at Chinook Therapeutics, Inc., a Nasdaq-listed biopharmaceutical company that was acquired by Novartis AG … Continued

Dr. King is Jade Biosciences’ Chief Scientific Officer, Head of Research and Development and most recently served as a consultant to Paragon Therapeutics from May 2024 to July 2024 to help build and launch Jade Biosciences. From June 2021 to October 2023, Dr. King served as Chief Scientific Officer and, from May 2019 to June … Continued

Dr. Hetal Kocinsky serves as Jade Biosciences’ Chief Medical Officer. Dr. Kocinsky brings deep expertise in drug development, having led clinical programs from early-stage research to regulatory approvals across multiple therapeutic areas. Most recently, she served as Vice President of Translational Medicine at Chinook Therapeutics, Inc., a Nasdaq-listed biopharmaceutical company acquired by Novartis AG in … Continued

Elizabeth Balta is the General Counsel and Corporate Secretary of Jade Biosciences. She most recently served as General Counsel of Icosavax, where she led all aspects of the company’s legal affairs from September 2021 until the acquisition of Icosavax by AstraZeneca in February 2024. Prior to joining Icosavax, Ms. Balta served as Associate General Counsel … Continued

Mr. Quick is the Senior Vice President of Finance at Jade Biosciences, bringing over 15 years of financial leadership in the biotechnology and pharmaceutical sectors. At Jade, he oversees the company’s finance, accounting, and treasury functions. Prior to joining Jade, he led financial operations at Myeloid Therapeutics, managing key areas such as accounting and treasury. … Continued

Valerie Fauvelle is the Senior Vice President of Regulatory & Quality at Jade Biosciences. She brings nearly 25 years of experience in the biotech and pharma industries where she developed expertise in regulatory submissions, compliance frameworks, and quality oversight. Prior to joining Jade, she held leadership roles at several companies, including Chinook Therapeutics, where she … Continued

Dr. Wright serves as Senior Vice President, Chemistry, Manufacturing and Controls (CMC) at Jade Biosciences. He brings 20 years of experience in managing CMC biologics programs.  Most recently Dr. Wright served as VP, CMC and then SVP, CMC at Apexigen, Inc. from Oct 2019 to Sep 2023 where he had responsibility for all CMC activities … Continued

Sandy Lewis is the Senior Vice President of Biometrics and Clinical Strategy at Jade Biosciences, bringing over 25 years of experience in biostatistics, clinical trial design, and global regulatory submissions. Most recently, she was Vice President of Biometrics at Chinook Therapeutics, where she built a high performing team and led biometrics strategy and clinical development. … Continued

Amy Sullivan is the Senior Vice President of Development Operations at Jade Biosciences. A veteran drug development leader with nearly three decades of experience, Amy has a proven track record of delivering successful clinical programs from early development through post-approval.   Before joining Jade Biosciences, Amy served as the Senior Vice President of Development Operations at … Continued